SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Boghos I Yerevanian, Young Mee Choi, Impact of psychotropic drugs on suicide and suicidal behaviors, Bipolar Disorders, 2013, 15, 5
  2. 2
    Hoda Moteshafi, Simon Zhornitsky, Sarah Brunelle, Emmanuel Stip, Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders, Drug Safety, 2012, 35, 10, 819

    CrossRef

  3. 3
    Ralph J. Koek, Boghos I. Yerevanian, Jim Mintz, Subtypes of antipsychotics and suicidal behavior in bipolar disorder, Journal of Affective Disorders, 2012, 143, 1-3, 27

    CrossRef

  4. 4
    Georg Nikisch, Pierre Baumann, Georg Wiedemann, Bernhard Kiessling, Heike Weisser, Andreas Hertel, Takashi Yoshitake, Jan Kehr, Aleksander A. Mathé, Quetiapine and Norquetiapine in Plasma and Cerebrospinal Fluid of Schizophrenic Patients Treated With Quetiapine, Journal of Clinical Psychopharmacology, 2010, 30, 5, 496

    CrossRef

  5. 5
    Anna J. Esbensen, Jan S. Greenberg, Marsha Mailick Seltzer, Michael G. Aman, A Longitudinal Investigation of Psychotropic and Non-Psychotropic Medication Use Among Adolescents and Adults with Autism Spectrum Disorders, Journal of Autism and Developmental Disorders, 2009, 39, 9, 1339

    CrossRef

  6. 6
    Chad A. Noggle, Raymond S. Dean, Atypical and typical antipsychotics in the schools, Psychology in the Schools, 2009, 46, 9
  7. 7
    Vivek Datta, Anthony J Cleare, Recent advances in bipolar disorder pharmacotherapy: focus on bipolar depression and rapid cycling, Expert Review of Clinical Pharmacology, 2009, 2, 4, 423

    CrossRef

  8. 8
    Frank D. Gianfrancesco, Martha Sajatovic, Krithika Rajagopalan, Ruey-Hua Wang, The association between treatment adherence and antipsychotic dose among individuals with bipolar disorder, International Clinical Psychopharmacology, 2008, 23, 6, 305

    CrossRef

  9. 9
    J. John Mann, The Medical Management of Depression, New England Journal of Medicine, 2005, 353, 17, 1819

    CrossRef